|
|||||
|
|

Real estate services firm Cushman & Wakefield (NYSE:CWK) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 10.8% year on year to $2.91 billion. Its non-GAAP profit of $0.54 per share was in line with analysts’ consensus estimates.
Is now the time to buy CWK? Find out in our full research report (it’s free for active Edge members).
Cushman & Wakefield’s fourth quarter results came in ahead of Wall Street’s revenue expectations, but the market response was negative. Management attributed the quarter’s performance to momentum in its capital markets business, which delivered double-digit growth, and resilient leasing activity across regions. CEO Michelle MacKay emphasized the company’s progress in breaking down organizational silos and leveraging technology, while also acknowledging the impact of higher annual healthcare costs and a non-cash impairment related to its Greystone joint venture.
Looking ahead, Cushman & Wakefield’s outlook is shaped by its three-year growth plan, continued investment in technology, and the evolving role of artificial intelligence in commercial real estate. Management is focused on maintaining balanced capital allocation between deleveraging and organic growth, while expecting service line trends to mirror those of last year. MacKay stated, “Our model aligns client success with our success, and we have compelling financial targets that we believe will generate long-term shareholder value.”
Management highlighted strong momentum in capital markets and leasing, ongoing investment in digital capabilities, and a focus on operating leverage to drive future growth.
Cushman & Wakefield expects steady growth in 2026, driven by technology adoption, resilient service lines, and continued capital markets recovery, while monitoring sector-specific risks and maintaining cost discipline.
Going forward, the StockStory team will be tracking (1) the pace of AI-enabled service adoption and its impact on cross-selling across business lines, (2) continued momentum in capital markets as transaction activity and asset values evolve, and (3) the effectiveness of cost management and operating leverage as the company invests in technology and talent. Updates on organizational structure and sector-specific demand shifts will also be important markers.
Cushman & Wakefield currently trades at $13.23, down from $13.56 just before the earnings. At this price, is it a buy or sell? The answer lies in our full research report (it’s free).
Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.
The names generating the next wave of massive growth are right here in our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
| Mar-11 | |
| Mar-09 | |
| Mar-06 | |
| Mar-05 | |
| Mar-05 | |
| Mar-04 | |
| Mar-03 | |
| Mar-02 | |
| Mar-01 | |
| Feb-26 | |
| Feb-26 | |
| Feb-25 | |
| Feb-23 | |
| Feb-23 | |
| Feb-21 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about Finviz Elite